Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

A Chip with Blood Vessels

13.11.2018

Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.

Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more difficult task. Important transport processes in biology, for example the transport of oxygen, sugar and other substances into the tissue, have not yet been fully understood.


In any of the four chambers, different conditions can be created, which influence cell growth.


The Cell Chip Group: Mario Rothbauer, Peter Ertl, Barbara Bachmann (left to right)

This is now going to change with a completely new approach to the problem: At the Vienna University of Technology, tissue is being grown on the biochip – so-called "organs-on-a-chip".

This allows you to precisely control and measure complicated biological processes – much better than would be possible in animal testing or by experimenting on humans.
Better than animal experiments

"Around a fresh wound, new tissue has to regrow, in which, among other things, new blood vessels form," says Dipl-Ing. Barbara Bachmann of the Institute of Applied Synthetic Chemistry at TU Wien. "We use the body’s natural wound healing processes to grow blood vessels in the lab in tiny biochips."

For a long time, such research projects relied exclusively on animal experiments. "Animal experiments have many disadvantages – not only from an ethical point of view, but also on a scientific level," says group leader Prof. Peter Ertl. "The results can never be perfectly transferred to humans, and so there are often surprising side effects in clinical trials that never showed up in animal models."

With biochip technology, it is now possible to regulate the substances with which the human vascular cells are supplied with great precision. This makes it possible to cultivate and study human cells over the course of several weeks.

"In addition to endothelial cells that line the inside of the vessels, we also use stem cells that play a key role in stabilizing the vascular structures," says Mario Rothbauer. "Almost magically, a network of tiny blood vessels emerges in the biochip within a few days."

A tiny influx pipe, through which the tissue is supplied with oxygen and nutrients from outside, passes through the tissue next to this newly formed network of fine blood capillaries – it is the "artificial artery" of the biochip.

The fine, naturally-grown blood vessels are not directly connected to this artificial conduit, but the boundaries between the two areas are not densely sealed off, so that chemicals can pass through.

"This is a situation that is frequently encountered in medicine," says Prof. Peter Ertl: "For example in wound healing, but also in diseases such as cancer." A fast-growing tumor must find a way to obatin sufficient amounts of nutrients, therefore it usually causes an unnaturally fast growth of fine blood capillaries. This mass transfer between the tumor and the rest of the body can now be investigated much better in the chip.

"We were able to show that the supply actually depends on the distance to the influx pipe, as it would be the case in natural tissue," says Dipl.-Ing. Sarah Spitz. "And another crucial finding was that we have been able to show that the nutrient supply to the tissue can be fine-tuned by changing the flow velocity in the biochips – it's that simple."
Interdisciplinary research

In this field of research, several scientific disciplines are closely connected: medicine and chemistry, but also microfluidics (the science of the flow behavior of tiny amounts of liquids), or even material science and manufacturing technology had to be combined to make the precise production of the chips possible. TU Wien collaborated with the Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, and was supported by the "Interreg" funding program of the European Union.

"Only through this interdisciplinary approach can we take on a leading role achieve research results that cause a stir internationally," says Peter Ertl. "Our results show that the biochips provide an excellent model to study oxygenation in newly formed tissues. This is just the beginning for us. Remarkable new research opportunities are just opening up."


More information:

Engineering of three-dimensional pre-vascular networks within fibrin hydrogel constructs by microfluidic control over reciprocal cell signaling


Contact:
Prof. Peter Ertl
Institute for Applied Synthetic Chemistry
TU Wien
Getreidemarkt 9, 1060 Vienna
T: +43-1-58801-163605
peter.ertl@tuwien.ac.at

Dipl.-Ing. Barbara Bachmann (barbara.bachmann@tuwien.ac.at)
Dr. Mario Rothbauer (mario.rothbauer@tuwien.ac.at)
Sarah Spitz (sarah.spitz@tuwien.ac.at)
Institute for Applied Synthetic Chemistry
TU Wien
Getreidemarkt 9, 1060 Vienna
T: +43-1-58801-163724

Dr. Florian Aigner | Technische Universität Wien
Further information:
http://www.tuwien.ac.at

More articles from Life Sciences:

nachricht Lethal combination: Drug cocktail turns off the juice to cancer cells
12.12.2018 | Universität Basel

nachricht Smelling the forest – not the trees
12.12.2018 | Universität Konstanz

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Lethal combination: Drug cocktail turns off the juice to cancer cells

A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.

The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...

Im Focus: New Foldable Drone Flies through Narrow Holes in Rescue Missions

A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.

Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...

Im Focus: Topological material switched off and on for the first time

Key advance for future topological transistors

Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...

Im Focus: Researchers develop method to transfer entire 2D circuits to any smooth surface

What if a sensor sensing a thing could be part of the thing itself? Rice University engineers believe they have a two-dimensional solution to do just that.

Rice engineers led by materials scientists Pulickel Ajayan and Jun Lou have developed a method to make atom-flat sensors that seamlessly integrate with devices...

Im Focus: Three components on one chip

Scientists at the University of Stuttgart and the Karlsruhe Institute of Technology (KIT) succeed in important further development on the way to quantum Computers.

Quantum computers one day should be able to solve certain computing problems much faster than a classical computer. One of the most promising approaches is...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

ICTM Conference 2019: Digitization emerges as an engineering trend for turbomachinery construction

12.12.2018 | Event News

New Plastics Economy Investor Forum - Meeting Point for Innovations

10.12.2018 | Event News

EGU 2019 meeting: Media registration now open

06.12.2018 | Event News

 
Latest News

New discoveries predict ability to forecast dementia from single molecule

12.12.2018 | Health and Medicine

CCNY-Yale researchers make shape shifting cell breakthrough

12.12.2018 | Physics and Astronomy

Pain: Perception and motor impulses arise in the brain independently of one another

12.12.2018 | Health and Medicine

VideoLinks
Science & Research
Overview of more VideoLinks >>>